Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

A/S, a global healthcare company specializing in diabetes care and other chronic conditions, has been at the forefront of the rapidly expanding GLP-1 market. With a market capitalization of $376.79 ...

Sarah Bool is calling for a list of conditions that should and should not be included in the controversial bill, due to ...

Novo Nordisk’s NVO shares gained 8.5% on Friday after the company announced positive top-line data from an early to mid-stage ...

As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...

Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.

The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

Learn how diabetes medications could revolutionize stroke prevention and enhance heart and brain health with breakthrough ...